National program for point-of-care testing of Hepatitis C in Australia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This program aims to evaluate the effectiveness of finger-stick point-of-care testing for Hepatitis C (HCV) in increasing diagnosis and treatment rates among at-risk populations. Participants will be recruited from various settings, including drug treatment clinics and prisons, where they will undergo HCV RNA testing and complete a survey in a single visit. The study focuses on improving HCV treatment uptake to reduce the disease burden and aims to link those who test positive to standard care. The Kirby Institute, a leader in HCV research, will oversee the program.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Provided informed consent.
2. ≥ 18 years of age.
3. Have a risk factor for the acquisition of HCV infection (including current or past injecting drug use, previous incarceration, HIV infection, receiving blood products prior to 1990, having a tattoo or piercing in an unregulated environment, a needle-stick injury, or a mother with HCV).

   OR:
4. Are attending a service caring for people with risk factors for the acquisition of HCV infection (e.g. drug treatment clinics, needle and syringe programs, prisons, mobile outreach services, community health services, mental health services, and homelessness services).

Exclusion Criteria:

a. Is unable or unwilling to provide informed consent or abide by the requirements of the study.

Where it's running

• Hepatitis ACT
  Canberra, Australian Capital Territory, Australia Recruiting
• Western NSW LHD
  Bathurst, New South Wales, Australia Recruiting
• Central Coast LHD
  Gosford, New South Wales, Australia Recruiting
• Nepean Blue Mountains LHD
  Penrith, New South Wales, Australia Recruiting
• North and Mid North Coast LHD
  Port Macquarie, New South Wales, Australia Recruiting
• Kirketon Road Centre
  Sydney, New South Wales, Australia Recruiting

+19 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Study coordinator: David C Silk, BSc
• Email: dsilk@kirby.unsw.edu.au
• Phone: +61293850900

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Glecaprevir/pibrentasvir started during pregnancy for women with hepatitis C, with or without HIV

  This trial will test whether taking glecaprevir/pibrentasvir during pregnancy is safe and how the drug is processed in pregnant women who have hepatitis C, including those who also have HIV, and will follow their infants for 10 weeks after birth.

  Recruiting at 8 sites Phase 1/2 National Institute of Allergy and Infectious Diseases (NIAID) · Los Angeles, California and 9 other locations · NCT07040319

• Evaluating hepatitis C treatment during pregnancy

  This study tests how well a new hepatitis C treatment works for pregnant adults with a history of drug use and looks at their experience during the treatment.

  Recruiting at 2 sites Washington University School of Medicine · St Louis, Missouri and 1 other locations · NCT06367465

• Decentralized treatment for hepatitis C in Brazil

  This study is testing a new way to treat hepatitis C in Brazil using a medication called Epclusa to see if it helps more people get the care they need compared to traditional methods.

  Recruiting at 2 sites Phase 4 Oswaldo Cruz Foundation · Rio de Janeiro, Rio de Janeiro and 1 other locations · NCT06306300

• Helping young people who inject drugs start treatment for Hepatitis C

  This study tests a new support program to help young adults who inject drugs start treatment for Hepatitis C and see if it works better than regular care.

  Recruiting University of California, San Francisco · San Francisco, California · NCT06179498

• Simplified hepatitis C testing with same-day treatment for people who inject drugs in Armenia, Georgia and Tanzania

  This project will test whether a simplified pathway that starts hepatitis C treatment the same day after a quick antibody test helps people who inject drugs in Armenia, Georgia, and Tanzania get treated and cured faster than the usual antibody-plus-RNA pathway.

  Recruiting Early Phase 1 Médecins du Monde · Yerevan · NCT06159504

• Point-of-care testing program for Hepatitis C screening

  This study is testing if quick Hepatitis C tests done during a single visit can help more at-risk adults get diagnosed and start treatment faster.

  Recruiting at 6 sites Kirby Institute · Canberra, Australian Capital Territory and 12 other locations · NCT05713136

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.